内源性DNA加合物作为肝细胞癌发生的预后生物标志物及Theaphenon E在小鼠中的预防作用
研究在两种易发肝细胞癌的小鼠模型中检测γ-OHPdG水平,并分析两组肝癌患者标本中γ-OHPdG与生存及无复发生存的关系。结果显示γ-OHPdG随年龄升高并与肝癌发生相关,Theaphenon E可降低其水平并减少肝癌发生率;患者中较高γ-OHPdG与低生存和无复发生存相关。
要点
- γ-OHPdG在三种动物模型中随年龄升高并与肝癌发生一致相关。
- Theaphenon E使XPA敲除小鼠肝癌发生率从对照组的100%降至14%。
- 两组患者中较高γ-OHPdG与低生存(P<0.0001)和低无复发生存(P=0.007)相关。
核心结论
- 结果支持γ-OHPdG作为基于机制、具有生物学相关性的生物标志物,用于预测肝细胞癌发生及复发风险。
研究设计与样本
- 在XPA敲除小鼠和二乙基亚硝胺注射小鼠两种易发肝细胞癌的动物模型中进行生物测定,并检测肝脏γ-OHPdG水平。
- 使用两组独立的肝细胞癌患者标本,分析γ-OHPdG与生存或无复发生存的关系。
主要发现
- 肝脏DNA中γ-OHPdG水平呈年龄依赖性升高,并在三种动物模型中均与肝细胞癌发生一致相关。
- Theaphenon E显著降低XPA敲除小鼠肝脏DNA中γ-OHPdG水平,并使肝癌发生率从对照组的100%降至14%。
- Theaphenon E也有效抑制二乙基亚硝胺注射小鼠的肝癌发生。
- 两组患者标本中,较高γ-OHPdG水平与低生存强烈相关(P<0.0001)。
- 两组患者标本中,较高γ-OHPdG水平与低无复发生存相关(P=0.007)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide, mainly because of its poor prognosis. A valid mechanism-based prognostic biomarker is urgently needed. γ-hydroxy-1,N2 -propanodeoxyguanosine (γ-OHPdG) is an endogenously formed mutagenic DNA adduct derived from lipid peroxidation. We examined the relationship of γ-OHPdG with hepatocarcinogenesis in two animal models and its potential role as a prognostic biomarker for recurrence in HCC patients. Bioassays were conducted in xeroderma pigmentosum group A knockout mice and diethylnitrosamine-injected mice, both prone to HCC development. γ-OHPdG levels in the livers of these animals were determined. The effects of antioxidant treatments on γ-OHPdG and hepatocarcinogenesis were examined. Using two independent sets of HCC specimens from patients, we examined the relationship between γ-OHPdG and survival or recurrence-free survival. γ-OHPdG levels in liver DNA showed an age-dependent increase and consistently correlated with HCC development in all three animal models. Theaphenon E treatment significantly decreased γ-OHPdG levels in the liver DNA of xeroderma pigmentosum group A knockout mice and remarkably reduced HCC incidence in these mice to 14% from 100% in the controls. It also effectively inhibited HCC development in the diethylnitrosamine-injected mice. Using clinical samples from two groups of patients, our study revealed that higher levels of γ-OHPdG are strongly associated with low survival (P < 0.0001) and low recurrence-free survival (P = 0.007). CONCLUSION: These results support γ-OHPdG as a mechanism-based, biologically relevant biomarker for predicting the risk of HCC and its recurrence. (Hepatology 2018;67:159-170).
引用
- Fu Y, Silverstein S, McCutcheon JN, et al. An endogenous DNA adduct as a prognostic biomarker for hepatocarcinogenesis and its prevention by Theaphenon E in mice. Hepatology. 2017. PMID: 28718980. doi:10.1002/hep.29380
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。